Results 11 to 20 of about 246,759 (191)

Autoimmune haemolytic anaemia secondary to COVID-19 infection presenting as anaemia-induced unstable angina

Asian Journal of Internal Medicine, 2023
Autoimmune haemolytic anaemia (AIHA) is a condition characterised by antibody mediated haemolysis. COVID-19 infection has been associated with multiple extra pulmonary complications of autoimmune origin, including AIHA.
P. Samarasinghe, J. Janya, S. Balachandren, H. Jayawardene, W. W. L. A. Jayanaga   +4 more
doaj   +2 more sources

Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome [PDF]

European Journal of Case Reports in Internal Medicine, 2019
The presence of different autoimmune disorders in the same individual is called multiple autoimmune syndrome (MAS). One of these co-occurring conditions is autoimmune haemolytic anaemia (AIHA), which is characterized by the production of autoantibodies ...
Mohammad Mahdi Adib Sereshki, Simin Almasi, Behdad Behnam, Farbod Semnani   +3 more
doaj   +2 more sources

Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil [PDF]

Case Reports in Hematology, 2016
Autoimmune haemolytic anaemia is not a well-recognised complication of sarcoidosis. We describe the case of a 30-year-old female who presented with acute warm haemolytic anaemia and widespread lymphadenopathy.
Sarah Green, Erica Partridge, Edore Idedevbo, Anton Borg   +3 more
doaj   +2 more sources

Autoimmune haemolytic anaemia and fever of undetermined origin as presenting manifestations of hodgkin disease: A case report

International Journal of Medicine and Health Development, 2010
Introduction: Autoimmune haemolytic anaemia is an important cause of acute or chronic anaemia. Its association with lymphoproliferative disorders such as non-Hodgkin lymphoma, and Hodgkin disease is well documented in the literature. Subjects and Methods:
S N Uwaezuoke, H U Okafor, S Ocheni, O C Okafor   +3 more
doaj   +2 more sources

Antibodies to actin in autoimmune haemolytic anaemia [PDF]

BMC Veterinary Research, 2010
Background In autoimmune haemolytic anaemia (AIHA), autoreactive antibodies directed against red blood cells are up-regulated, leading to erythrocyte death. Mycoplasma suis infections in pigs induce AIHA of both the warm and cold types.
Ritzmann Mathias, Heinritzi Karl, Hoelzle Katharina, Felder Kathrin M, Hoelzle Ludwig E   +4 more
doaj   +2 more sources

Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma

Case Reports in Oncology, 2017
Autoimmune haemolytic anaemia (AIHA) in mantle cell lymphoma (MCL) is a rare but life-threatening complication. To date, there are no relevant data for treatment of AIHA in MCL.
Aliénor Galinier, Vincent Delwail, Mathieu Puyade   +2 more
doaj   +2 more sources

Aberrant microRNA expression in B lymphocytes from patients with primary warm autoimmune haemolytic anaemia

Autoimmunity, 2021
Objective To screen and analyze the micro-Ribonucleic Acid (miRNA) expression profile in B lymphocytes from patients with autoimmune haemolytic anaemia (AIHA) using high-throughput sequencing.
Manjun Zhao, Xin He, Jin Yang, Yingying Feng, Huaquan Wang, Zonghong Shao, Limin Xing   +6 more
doaj   +2 more sources

Delayed autoimmune haemolytic anaemia after artesunate therapy for severe malaria. [PDF]

BMJ Case Rep, 2022
We report the case of a 51-year-old man with severe malaria, who developed delayed autoimmune haemolytic anaemia following artesunate therapy. Delayed autoimmune haemolytic anaemia following artesunate therapy has been previously described. Its diagnosis
Abohelwa M, Agusala V, Hassan M, Gharamti A.   +3 more
europepmc   +2 more sources

Lead Toxicity Masquerading as Autoimmune Haemolytic Anaemia: A Diagnostic Pitfall in Unexplained Anaemia. [PDF]

Cureus
Lead toxicity is an uncommon but clinically important cause of unexplained anaemia. Its heterogeneous haematological manifestations can mimic autoimmune haemolytic anaemia, resulting in diagnostic uncertainty and delayed recognition.\ua0 A 49-year-old ...
Chew JE, Klose N.
europepmc   +2 more sources

Treatment of Autoimmune Haemolytic Anaemia with Hepatitis C Virus-A Real Challenge

Sri Lankan Journal of Infectious Diseases, 2016
Hepatitis C virus (HCV) infection is a potentially curable disease. The first line of treatment is pegylated interferon and ribavirin, both of which cause haemolysis. HCV itself causes autoimmune haemolytic anaemia (AIHA).
A Basu, D Nidhi, R Mehebubar, R Yogiraj, G Rama Prosad   +4 more
doaj   +2 more sources